The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The diphtheria market has exhibited robust growth, surging from $8.34 billion in 2023 to a projected $8.91 billion in 2024, reflecting a commendable Compound Annual Growth Rate (CAGR) of 6.9%. This momentum is expected to continue, with the market reaching $11.51 billion in 2028, driven by a CAGR of 6.6%. Key factors contributing to this growth include vaccine development, immunization campaigns, increased awareness, and the expansion of healthcare infrastructure. As we delve into the market dynamics, let’s explore the rising prevalence of bacterial infections, innovations in drug development, and strategic partnerships shaping the future of diphtheria prevention.

Rising Prevalence of Bacterial Infections Fuels Growth in the Diphtheria Market

• Impact of Bacterial Infections
  • Bacterial infections, such as those caused by Acinetobacter and Klebsiella pneumonia, are on the rise globally.
  • Antimicrobial-resistant infections and their fatalities underscore the urgent need for preventive measures.
• European Centre for Disease Prevention and Control Report
  • In 2021, Acinetobacter species resistant to various antimicrobial groups doubled the average.
  • Klebsiella pneumonia cases increased by 31% in 2020 and an additional 20% in 2021.
• Driving Force
  • The escalating prevalence of bacterial infections, with their associated risks, is a key driver of the diphtheria market.

Read More On The Diphtheria Market Report 2023 –
https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

Companies Innovate and Gain FDA Approval for Diphtheria Prevention Drugs

• Innovative Drug Development
  • Companies in the diphtheria market are focused on developing cutting-edge drugs to prevent and manage diphtheria.
  • GlaxoSmithKline PLC gains FDA approval for BOOSTRIX, a Tdap vaccine administered during the third month of pregnancy.
• BOOSTRIX Approval
  • BOOSTRIX aims to prevent pertussis in infants younger than two months by transferring protective antibodies from vaccinated mothers.
• Strategic Collaborations
  • Pharmaniaga LifeScience partners with BioNet to develop a Hexavalent Vaccine, covering diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b, and hepatitis B.

Pharmaniaga LifeScience Partners with BioNet to Develop Hexavalent Vaccine for Self-Sufficiency

• Collaborative Research Contract
  • Pharmaniaga LifeScience collaborates with BioNet-Asia to develop a 6-in-1 Hexavalent Vaccine.
  • The vaccine targets diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b, and hepatitis B.
• Strategic Objectives
  • Aligns with Pharmaniaga’s goal to establish the world’s first Halal vaccine and insulin factories.
  • Aims to reduce Malaysia’s dependence on imported vaccines, fostering self-sufficiency.
• BioNet-Asia’s Expertise
  • BioNet-Asia, a Thailand-based company, brings expertise in manufacturing life-saving vaccines for bacterial infections.

Market Segmentation and Strategic Trends

• Market Segmentation
  • By Type: Diphtheria, Skin Diphtheria, Other Types.
  • By Diagnosis: Physical Examination, Throat Culture, Other Diagnosis.
  • By Treatment: Antibiotics, Antitoxin, Other Treatments.
  • By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy.
  • By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users.
• Strategic Trends
  • Combination vaccines, incorporating multiple preventive components, emerge as a significant trend.
  • Telemedicine for vaccination gains prominence, enhancing accessibility and outreach.
  • Vaccine equity initiatives and public-private partnerships play a pivotal role in ensuring widespread immunization.

Request for A Sample Of The Global Diphtheria Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13016&type=smp

The Table Of Content For The Diphtheria Market Include:

1. Diphtheria Market Executive Summary
2. Diphtheria Market Segments
3. Diphtheria Market Size And Diphtheria Market Growth Rate
4. Key Diphtheria Market Trends
5. Major Diphtheria Market Drivers
……
25. Key Mergers And Acquisitions In The Diphtheria Market
26. Top Diphtheria Companies
27. Diphtheria Market Opportunities And Strategies
28. Diphtheria Market, Conclusions And Recommendations
29. Appendix

The Diphtheria Market Global Market Report 2023 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the diphtheria market.

View More Reports Related To The Market –
Pharmacies And Healthcare Stores Global Market Report 2023
Pharmaceutical Drugs Global Market Report 2023
Pharmaceutical Drug Delivery Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model